Published

Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2026-05-24
Source: Europe PMC
DOI: 10.1177/00048674261450390
PubMed: 42198984

Authors

Giri Y Furst P Loo CK Clark SR Tibrewal P.

Watch author

Derived topics and classifications

psilocybin Depression Treatment-Resistant Depression Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.Unknown journal · 2025-05-21 [Psychedelic and dissociative agents in psychiatry: challenges in the treatment].Unknown journal · 2024-08-27 Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.Journal of Psychosocial Nursing and Mental Health Services · 2016-06-30 Behandeling met psilocybineData Archiving and Networked Services (DANS) · 2021-01-20